Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5182084
Max Phase: Preclinical
Molecular Formula: C20H18O3
Molecular Weight: 306.36
Associated Items:
ID: ALA5182084
Max Phase: Preclinical
Molecular Formula: C20H18O3
Molecular Weight: 306.36
Associated Items:
Canonical SMILES: Oc1cccc(OCC(O)c2ccc(-c3ccccc3)cc2)c1
Standard InChI: InChI=1S/C20H18O3/c21-18-7-4-8-19(13-18)23-14-20(22)17-11-9-16(10-12-17)15-5-2-1-3-6-15/h1-13,20-22H,14H2
Standard InChI Key: JAQNVEKGPATCCV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 306.36 | Molecular Weight (Monoisotopic): 306.1256 | AlogP: 4.17 | #Rotatable Bonds: 5 |
Polar Surface Area: 49.69 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.48 | CX Basic pKa: | CX LogP: 4.25 | CX LogD: 4.25 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.74 | Np Likeness Score: -0.09 |
1. Karlov DS, Temnyakova NS, Vasilenko DA, Barygin OI, Dron MY, Zhigulin AS, Averina EB, Grishin YK, Grigoriev VV, Gabrel'yan AV, Aniol VA, Gulyaeva NV, Osipenko SV, Kostyukevich YI, Palyulin VA, Popov PA, Fedorov MV.. (2022) Biphenyl scaffold for the design of NMDA-receptor negative modulators: molecular modeling, synthesis, and biological activity., 13 (7.0): [PMID:35923717] [10.1039/d2md00001f] |
Source(1):